US clinical trials often involve a second, parallel clinical trial in India, because it's easy to find lots of poor patients in desperate need of treatment. I think that, at least in some cases, this probably works out well for everyone except the control group.

But if poor Indian patients are going to test these drugs, the GP can certainly argue that poor Indian patients should be able to afford them.